Creative medical technology holdings announces reverse stock split

Phoenix , june 9, 2023 /prnewswire/ -- creative medical technology holdings, inc. ("creative medical technology" or the "company") (nasdaq: celz), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today announced that the company's board of directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 10 (the "reverse stock split"). the reverse stock split will become effective at 9:00 a.m.
CELZ Ratings Summary
CELZ Quant Ranking